Enveric Biosciences Inc.

NASDAQ: ENVB · Real-Time Price · USD
1.08
-0.03 (-2.70%)
At close: Aug 15, 2025, 3:57 PM
1.11
2.78%
After-hours: Aug 15, 2025, 04:38 PM EDT

Enveric Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.57M -17.29M -18.47M -48.98M
Depreciation & Amortization
337.49K 408.03K 435.2K 681.61K
Stock-Based Compensation
1.56M 2.15M 2.62M 12.6M
Other Working Capital
411.39K -70.9K -481.35K 801.87K
Other Non-Cash Items
372.21K 813.88K -9.3K 30.51M
Deferred Income Tax
n/a n/a -1.5M -7.45M
Change in Working Capital
-423.24K -174.75K -217.66K 1.19M
Operating Cash Flow
-7.73M -14.09M -17.15M -11.46M
Capital Expenditures
n/a -5.18K -584.16K -864.72K
Cash Acquisitions
n/a n/a 958.04K 3.06M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 16.85K -958.04K -675
Investing Cash Flow
n/a 11.67K -584.16K 2.19M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
1.08M -1.05M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.3M -291.08K 958.04K 3.29M
Financial Cash Flow
7.67M -1.34M 18.18M 24.9M
Net Cash Flow
-46.95K -15.44M 367.88K 15.78M
Free Cash Flow
-7.73M -14.1M -17.73M -12.32M